Fireside chats

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

Retrieved on: 
목요일, 5월 9, 2024

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:

Key Points: 
  • Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:
    Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in New York, NY
    Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m. Eastern Time in New York, NY
    Fireside Chat: Wednesday, May 16, 2024 at 12:20 p.m. Eastern Time in Las Vegas, NV
    Live webcasts of each fireside chat will be accessible on the company’s website, Acadia.com , under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

Fulcrum Therapeutics to Participate in Upcoming May Conferences

Retrieved on: 
목요일, 5월 9, 2024

ET.

Key Points: 
  • ET.
  • ET.
  • (Fireside Chat)
    The webcast of the presentation will be accessible by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations .
  • A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.

Aura Biosciences to Participate in Upcoming Investor Conferences

Retrieved on: 
수요일, 5월 8, 2024

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:

Key Points: 
  • BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:
    The Citizens JMP Life Sciences Conference on Monday, May 13, 2024.
  • Fireside Chat at 9:00 a.m.
  • ET.
  • TD Cowen 5th Annual Oncology Innovation Summit on Wednesday, May 29, 2024.

Altimmune to Participate at Two Upcoming Investor Conferences

Retrieved on: 
화요일, 5월 7, 2024

GAITHERSBURG, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:

Key Points: 
  • GAITHERSBURG, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:
    JMP Life Sciences Conference (New York, NY)
    Fireside Chat at 9:00 a.m. Eastern Time
    Fireside Chat at 10:00 a.m. Eastern Time
    The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

Arbutus to Participate in Two Upcoming Investor Conferences

Retrieved on: 
화요일, 5월 7, 2024

WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York:

Key Points: 
  • WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York:
    The Citizens JMP Life Sciences Conference: Fireside Chat on May 14, 2024 at 9:30 am ET
    H.C. Wainwright 2nd Annual BioConnect Investor Conference: Fireside Chat on May 20, 2024 at 3:30 pm ET
    To access the live webcast of the fireside chats please visit: https://investor.arbutusbio.com/events-presentations .
  • An archived replay of the webcast will be available on the Arbutus website for a limited time after the event.

Alarm.com to Participate in Upcoming Investor Conferences

Retrieved on: 
수요일, 5월 8, 2024

Alarm.com Holdings, Inc. (Nasdaq: ALRM), the leading platform for the intelligently connected property, today announced that Steve Valenzuela, Chief Financial Officer, will participate in and host one-on-one investor meetings at the following upcoming investor conferences.

Key Points: 
  • Alarm.com Holdings, Inc. (Nasdaq: ALRM), the leading platform for the intelligently connected property, today announced that Steve Valenzuela, Chief Financial Officer, will participate in and host one-on-one investor meetings at the following upcoming investor conferences.
  • 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference - Boston, MA
    Fireside Chat at 9:30 a.m.
  • ET
    Bank of America Global Technology Conference – San Francisco, CA
    Fireside Chat at 8:40 a.m. PT
    Jefferies Software Conference – Newport, CA

Guardant Health to Participate in Upcoming Investor Conferences

Retrieved on: 
화요일, 5월 7, 2024

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.
  • Fireside Chat on Wednesday, May 15 at 10:40 a.m. PT / 1:40 p.m.
  • ET
    Leerink Partners 2024 Healthcare Crossroads Conference in Austin, Texas
    Fireside Chat on Wednesday, May 29 at 3:00 p.m. CT / 4:00 p.m.
  • ET
    Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com .

Arcellx to Participate in Two Upcoming Investor Conferences

Retrieved on: 
화요일, 5월 7, 2024

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in two upcoming investor conferences:

Key Points: 
  • Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in two upcoming investor conferences:
    Presentation: Tuesday, May 14 at 3:40 p.m. PT
    Fireside Chat: Tuesday, May 28 at 1:00 p.m. PT
    A live webcast of these discussions will be accessible from Arcellx’s website at www.arcellx.com in the Investors section.
  • A replay of the webcasts will be archived and available for 30 days following the event.

Equifax Announces Participation in May Investor Conferences

Retrieved on: 
월요일, 4월 29, 2024

ATLANTA, April 29, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) will participate in several upcoming investor conferences in May.

Key Points: 
  • ATLANTA, April 29, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) will participate in several upcoming investor conferences in May.
  • The company invites investors to join live webcasts of these Fireside Chat events at: https://investor.equifax.com/news-events/ir-calendar .
  • A replay of each of the Fireside Chats will be available within 24 hours after the event on the company's Investor Relations website.
  • Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the Morgan Stanley Business Services Conference on Thursday, May 9, 2024 and the Needham TMC Conference on Thursday, May 16, 2024.